BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/14/2017 4:00:08 AM | Browse: 808 | Download: 1076
 |
Received |
|
2017-04-07 15:04 |
|
Peer-Review Started |
|
2017-04-10 11:55 |
|
To Make the First Decision |
|
2017-06-08 00:29 |
|
Return for Revision |
|
2017-06-13 03:27 |
|
Revised |
|
2017-06-26 13:28 |
|
Second Decision |
|
2017-07-11 05:42 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2017-07-12 07:00 |
|
Articles in Press |
|
2017-07-12 07:00 |
|
Publication Fee Transferred |
|
2017-07-13 12:44 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2017-08-03 07:03 |
|
Publish the Manuscript Online |
|
2017-08-14 04:00 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Expression of Interleukin-26 is upregulated in inflammatory bowel disease
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Makoto Fujii, Atsushi Nishida, Hirotsugu Imaeda, Masashi Ohno, Kyohei Nishino, Shigeki Sakai, Osamu Inatomi, Shigeki Bamba, Masahiro Kawahara, Tomoharu Shimizu and Akira Andoh |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Atsushi Nishida, MD, PhD, Department of Medicine, Shiga University of Medical Science, Seta Tsukinowa, Otsu 520-2192, Japan. atsuda@belle.shiga-med.ac.jp |
| Key Words |
Inflammatory bowel disease; Interleukin-26; Myofibroblasts |
| Core Tip |
We investigated interleukin (IL)-26 expression in the inflamed mucosa of patients with inflammatory bowel disease (IBD) and characterized the biological function of IL-26 using human colonic subepithelial myofibroblasts. To our knowledge, this is the first report to state that IL-26 activates STAT1/3 and leads to the induction of IL-6 and IL-8 expression in non-transformed cells derived from human colon. We suggest that IL-26 plays a role in the pathophysiology of IBD through the induction of inflammatory mediators. |
| Publish Date |
2017-08-14 04:00 |
| Citation |
Fujii M, Nishida A, Imaeda H, Ohno M, Nishino K, Sakai S, Inatomi O, Bamba S, Kawahara M, Shimizu T, Andoh A. Expression of Interleukin-26 is upregulated in inflammatory bowel disease. World J Gastroenterol 2017; 23(30): 5519-5529 |
| URL |
http://www.wjgnet.com/1007-9327/full/v23/i30/5519.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v23.i30.5519 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
